Elanco Animal Health Inc (ELAN): Depreciation & Amortization
$680.00M
Year ended 2025-12-31
$693.00M
Trailing 12 months to 2026-06-30
-0.1%
3-year compound annual growth
+5.6%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $680.00M | +2.7% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $662.00M | -4.6% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $694.00M | +1.8% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $682.00M | -4.7% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $716.00M | +38.5% | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $517.00M | +64.6% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $314.00M | +6.1% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $296.00M | -7.0% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $318.40M | +25.2% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $254.40M | n/a | 2019-02-20, From 2016-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $680.00M | +2.7% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $41.60M | +26.8% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $337.50M | +3.6% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $141.69M | -17.5% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $55.66M | -1.8% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $79.56M | -17.5% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $85.60M | +18.1% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $487.00M | -2.0% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $44.52M | +18.0% |
Compare ELAN, JAZZ, PRGO, ONC side by side · Screen every company in Pharmaceutical Preparations ↗